EFI
TVGNW icon

EHP Funds Inc’s Tevogen Bio Warrant TVGNW Stock Holding History

EHP Funds Inc’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-291,719
Closed -$14.6K – 237
2023
Q3 		$14.6K Hold
291,719
– – 0.01% 215
2023
Q2 		$12K Hold
291,719
– – ﹤0.01% 246
2023
Q1 		$23.3K Hold
291,719
– – ﹤0.01% 248
2022
Q4 		$2K Sell
291,719
-499,506
-63% -$14.5K ﹤0.01% 325
2022
Q3 		$95K Buy
791,225
+24,600
+3% +$3.55K 0.02% 240
2022
Q2 		$123K Buy
+766,625
New +$181K 0.02% 234

Other funds holding TVGNW

FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

EHP Funds Inc's TVGNW Position: Q4 2023 in Review

EHP Funds Inc sold out of Tevogen Bio Warrant (TVGNW) in Q4 2023, closing a stake of 291,719 shares — an estimated $14.6K sold.

EHP Funds Inc first reported a position in TVGNW in Q2 2022 and held it in 6 quarters. The position peaked at $123K in Q2 2022. 48 funds tracked by Wall St. Rank hold TVGNW as of Q4 2023.

  • EHP Funds Inc reported no remaining Tevogen Bio Warrant position as of Q4 2023 after selling out during the quarter.
  • EHP Funds Inc sold 291,719 Tevogen Bio Warrant shares in Q4 2023, an estimated $14.6K.
  • EHP Funds Inc first reported a position in Tevogen Bio Warrant in Q2 2022 and held it in 6 quarters.
  • EHP Funds Inc's Tevogen Bio Warrant position peaked at $123K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q4 2023.

Based on EHP Funds Inc's 13F filing for Q4 2023, filed 14 Feb 2024.